Skip to main content
OpenTrials

Clinical trial condition

Genital Neoplasms, Female

Explore clinical trials studying Genital Neoplasms, Female. Study availability and eligibility vary by location and protocol.

4,602 public trials 1,046 recruiting studies
Refine in advanced search Browse all conditions

Genital Neoplasms, Female trial results

Completed

Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer

NCT02728258

Conditions
Adenocarcinoma, Adnexal Diseases, Carcinoma, +24 more
Locations
  • Yale University New Haven, Connecticut, United States
  • UM Sylvester Comprehensive Cancer Center at Deerfield Beach Deerfield Beach, Florida, United States
  • University of Miami Miller School of Medicine-Sylvester Cancer Center Miami, Florida, United States
  • Northside Hospital Atlanta, Georgia, United States
View all 43 locations
View Trial Details
Completed

Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers

NCT02178722

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +76 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • US Davis Cancer Center Sacramento, California, United States
  • University Of Colorado Cancer Center Aurora, Colorado, United States
View all 24 locations
View Trial Details
Completed

INOVATYON STUDY -International, Randomized Study in Patients With Ovarian Cancer

NCT01379989

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • Krankenhaus Der Barmherzigen Brueder Graz, AT, Austria
  • Univ. Clinic for Gynaecology and Obstetrics - Medical University of Innsbruck Innsbruck, AT, Austria
  • Medizinische Universitat Graz Graz, Austria
  • Univ. Klinik Frauenheilkunde AKH Vienna, Austria
View all 132 locations
View Trial Details
Completed

Sorafenib With or Without Paclitaxel and Carboplatin in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer

NCT00096200

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • Moffitt Cancer Center at Tampa General Hospital Tampa, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Case Western Reserve University Cleveland, Ohio, United States
  • Lake University Ireland Cancer Center Mentor, Ohio, United States
View Trial Details
Completed

Bevacizumab With or Without Everolimus in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

NCT00886691

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • Gynecologic Oncology Group of Arizona Phoenix, Arizona, United States
  • Providence Saint Joseph Medical Center/Disney Family Cancer Center Burbank, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
View all 45 locations
View Trial Details
Completed

OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian Cancer

NCT03180307

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • The Mayo Clinic - Phoenix Phoenix, Arizona, United States
  • University of Arizona Tucson, Arizona, United States
  • City of Hope Medical Center Duarte, California, United States
  • University of CA at Irvine Chao Cancer Center Orange, California, United States
View Trial Details

Related conditions